Yue-e Teng
Shenyang, 110001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrial.
Journal: Cancer cell
Published: March 08, 2025
Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: The Phase III MECCA Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 02, 2025
Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study.
Journal: Frontiers in oncology
Published: June 27, 2022
A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer.
Journal: Nature communications
Published: May 05, 2022
Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in China.
Journal: Annals of translational medicine
Published: January 15, 2022
FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis.
Journal: Annals of translational medicine
Published: March 12, 2021
Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China.
Journal: Journal of oncology
Published: November 23, 2020
Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological study.
Journal: International journal of cancer
Published: April 01, 2020
Biological and clinical significance of flap endonuclease‑1 in triple‑negative breast cancer: Support of metastasis and a poor prognosis.
Journal: Oncology reports
Published: March 19, 2020
Inhibition of FEN1 Increases Arsenic Trioxide-Induced ROS Accumulation and Cell Death: Novel Therapeutic Potential for Triple Negative Breast Cancer.
Journal: Frontiers in oncology
Published: July 23, 2019
Single nucleotide polymorphisms of casitas B-lineage lymphoma proto-oncogene-b predict outcomes of patients with advanced non-small cell lung cancer after first-line platinum based doublet chemotherapy.
Journal: Journal of thoracic disease
Published: May 01, 2018
Expression and Comparison of Cbl-b in Lung Squamous Cell Carcinoma and Adenocarcinoma.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: February 01, 2018
Last Updated: 09/26/2026